Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "pantothenate kinase-associated neurodegeneration" OR "Hallervorden-Spatz Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"pantothenate kinase-associated neurodegeneration" OR "Hallervorden-Spatz Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-associated Neurodegeneration (PKAN)
Intervention:
2 Enrolling by invitation Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Deferiprone
3 Active, not recruiting A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Placebo oral solution
4 Available Compassionate Use of Deferiprone in Patients With PKAN
Condition: Pantothenate Kinase-Associated Neurodegeneration
Intervention: Drug: Deferiprone
5 Recruiting NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
Condition: Neurodegeneration With Brain Iron Accumulation (NBIA)
Intervention:
6 Active, not recruiting Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
Conditions: Neurodegenerative Disease;   Iron Overload
Intervention: Drug: Deferiprone

Indicates status has not been verified in more than two years